Aptevo Therapeutics Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-106247
- Form type
- 10-Q
- CIK
- 0001671584
- Primary document
- https://www.sec.gov/Archives/edgar/data/1671584/000095017025106247/apvo-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aptevo Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-12.7M | - | - |
| Net Income | $-12.6M | - | - |
| Eps Basic | -30.84 | - | - |
| Eps Diluted | -30.84 | - | - |
| Cash And Equivalents | $9.4M | - | - |
| Total Assets | $15.6M | - | - |
| Total Liabilities | $9.1M | - | - |
| Shareholders Equity | $6.5M | - | - |
| Operating Cash Flow | $-13.7M | - | - |